A low glycaemic index breakfast cereal preferentially prevents children's cognitive performance from declining

Jeanet Ingwersen1, Margaret Anne Defeyter, David O Kennedy

  • 1Cognition and Communication Research Centre, Division of Psychology, University of Northumbria, Newcastle upon Tyne NE1 8ST, UK.

Appetite
|January 17, 2007
PubMed

Insights

Low glycaemic index (GI) breakfast cereals improve children's attention and memory. A study found that low GI options reduce cognitive decline throughout the morning compared to high GI cereals.

Area of Science:

  • Pediatric Nutrition
  • Cognitive Psychology
  • Food Science

Background:

  • Childhood attention and memory are crucial for academic success.
  • Breakfast cereal consumption is common among children.
  • The glycaemic index (GI) of foods may impact cognitive function.

Purpose of the Study:

  • To investigate the differential effects of high and low glycaemic index (GI) breakfast cereals on children's attention and memory.
  • To determine if cereal GI influences cognitive performance decline over the morning.

Main Methods:

  • A balanced cross-over design study involving 64 children aged 6-11 years.
  • Children consumed either a high GI or a low GI cereal on consecutive mornings.
  • Computerised tests assessed attention and memory pre-breakfast and at hourly intervals post-breakfast.

Main Results:

  • Children's cognitive performance generally declined throughout the morning.
  • A low GI cereal significantly reduced the decline in accuracy of attention compared to a high GI cereal.
  • Low GI cereal intake also significantly mitigated the decline in secondary memory performance.

Conclusions:

  • The glycaemic index of breakfast cereal plays a significant role in maintaining children's cognitive functions.
  • Low GI breakfast options may be beneficial for supporting sustained attention and memory in children.
  • Dietary choices, specifically cereal GI, can impact morning cognitive performance in school-aged children.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is also...
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...